Product Development
Mesoblast to seek advancement of heart failure cell therapy on 60% composite CV outcomes reduction
Jan 12, 2021 | 3:33 AM GMT
A composite analysis showing reductions in cardiac death, stroke and heart
Gathering data...
A composite analysis showing reductions in cardiac death, stroke and heart